integrin inhibitors (3B Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameintegrin inhibitors (3B Pharmaceuticals)
Drug Alias Nameradioimmunotherapeutic/diagnostic imaging agent (3B Pharmaceuticals)cell adhesion molecule modulators (3B Pharmaceuticals)
ClassificationBiologics > Protein drugs > Recombinant polypeptideRadiation-emitting products
Mechanisms of ActionIntegrin antagonists
TargetsIntegrin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator Companies3B Pharmaceuticals GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies3B Pharmaceuticals GmbH
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A